3-V Biosciences News
Most Popular 3-V Biosciences Story
3-V Biosciences garners $30M in venture funds
A start-up biotech company focused on infectious diseases and founded in part by Kleiner Perkins Caufield & Byers has rounded up $30 million in new investment capital to fund its next stage of Read more...
Latest Headlines
- August 6, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
